|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
6 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to cash used in operating activities | |||||
| Depreciation, amortization, and non-cash lease interest | |||||
| Allowance for expected credit losses | |||||
| Provision for excess and obsolete inventory | |||||
| Change in fair value of derivative liabilities | |||||
| Change in fair value of contingent earnout liability | |||||
| Amortization (accretion) of (discounts) premiums on available-for-sale securities | |||||
| Stock-based compensation expense | |||||
| Transaction costs expensed | |||||
| Loss on disposal of fixed assets | |||||
| Gain on operating lease termination | |||||
| Long-lived asset impairment | |||||
| Goodwill impairment | |||||
| Foreign exchange (gains) losses on intercompany transactions, net | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Other current liabilities | |||||
| Deferred rent | |||||
| Deferred revenue | |||||
| Other long term liabilities | |||||
| Other non-current lease liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from the sale of property, plant and equipment | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Purchases of available-for-sale securities | |||||
| Proceeds from sales and maturities of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities: | |||||
| Repayment of debt obligations | |||||
| Proceeds from Merger | |||||
| Proceeds from PIPE investment | |||||
| Repurchase of common stock | |||||
| Payment of transaction costs for the Merger | |||||
| Proceeds from exercise of Series D warrants | |||||
| Payment of acquisition-related contingent liabilities | |||||
| Acquisition holdback payment | |||||
| Proceeds from the exercise of common stock options | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Net cash provided by (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash | |||||
| Beginning of year | |||||
| End of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash and cash equivalents | |||||
| Restricted cash in other non-current assets | |||||
| Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows | |||||
| Additions to right of use assets and liabilities from adoption of ASC 842 | |||||
| Right of use assets obtained in exchange for new lease liabilities | |||||
| Non cash financing and investing activities | |||||
| Common stock issued in connection with acquisition earnout achievement | |||||
| Purchase of property and equipment in accounts payable and accrued expenses | |||||
| Common stock issued for acquisitions | |||||
| Recognition of contingent earnout liability related to earnout shares | |||||
| Recognition of one public warrant acquired as part of the Merger in additional paid in capital | |||||
| Recognition of private placement warrant liability upon Merger | |||||
| Exercise of common stock warrants, net of shares withheld for exercise | |||||
| Conversion of convertible preferred stock into common stock upon reverse recapitalization | |||||
| Acquisition of cross license | |||||
| Common stock disbursed to settle acquisition holdback | |||||
Loading...